Remotely Triggered Nano-Theranostics For Cancer Applications

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Nanotechnology enables smart theranostic platforms for integrated disease diagnosis, treatment initiation, and response monitoring.
• Recent in vivo experiments highlight the clinical potential of theranostics.

Purpose of the Study:

• To review remotely triggered theranostic nanoparticles for cancer applications, focusing on advances in the last five years.
• To summarize various triggering mechanisms and nanoparticle types used in nanotheranostics.

Main Methods:

• Review of literature on remotely triggered nanotheranostics for cancer.
• Focus on photodynamic, photothermal, ultrasound, electro-thermal, magneto-thermal, X-ray, and radiofrequency therapies.
• Emphasis on nanotheranostic platforms with in vivo success.

Main Results:

• Highlighted nanotheranostic platforms include photoactivatable nanoliposomes, plasmonic nanobubbles, and iron oxide nanoparticles.
• Various remote triggering mechanisms are effective for cancer theranostics.
• Strong evidence for the rapid evolution of nanotheranostics.

Conclusions:

• Nanotheranostic platforms are rapidly evolving and may soon offer unique advances in clinical cancer management.
• Challenges include ensuring reproducibility in synthesis and scale-up.
• Development of more predictive cancer models is crucial for rapid clinical impact.